This is gonna be a very solid stock once a US partnership is announced. FDA shouldn’t be a problem considering 2 already approved drugs being combined with no adverse effects.... hopefully we break $3 before the end of the month
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.